Answers are grounded in this paper and cite their sources.
= 40.7%). In contrast, the prognostic effect of ΔSUV66% was weaker, with a pooled HR of 1.83. Scans performed after 4 cycles (iPET4, HR: 3.20) showed slightly stronger prognostic performance than those after 2 cycles (iPET2, HR: 2.84). Interim PET/CT, particularly when utilizing the DS 5 threshold, is a strong biomarker for identifying high-risk DLBCL patients.
No takes yet. Share an insight, caveat, or question.
Albano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: